- Home
- KNOP vs GNFT Comparison
KNOP vs GNFT Comparison
Compare KNOP & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNOP
- GNFT
- Stock Information
- Founded
- KNOP 2013
- GNFT 1999
- Country
- KNOP United Kingdom
- GNFT France
- Employees
- KNOP N/A
- GNFT N/A
- Industry
- KNOP Marine Transportation
- GNFT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- KNOP Consumer Discretionary
- GNFT Health Care
- Exchange
- KNOP Nasdaq
- GNFT Nasdaq
- Market Cap
- KNOP 187.6M
- GNFT 172.2M
- IPO Year
- KNOP 2013
- GNFT 2019
- Fundamental
- Price
- KNOP $5.76
- GNFT $3.60
- Analyst Decision
- KNOP
- GNFT Strong Buy
- Analyst Count
- KNOP 0
- GNFT 1
- Target Price
- KNOP N/A
- GNFT $13.00
- AVG Volume (30 Days)
- KNOP 89.3K
- GNFT 3.7K
- Earning Date
- KNOP 02-24-2025
- GNFT 09-19-2024
- Dividend Yield
- KNOP 1.81%
- GNFT N/A
- EPS Growth
- KNOP N/A
- GNFT N/A
- EPS
- KNOP N/A
- GNFT 0.47
- Revenue
- KNOP $299,790,000.00
- GNFT $86,225,222.00
- Revenue This Year
- KNOP $7.66
- GNFT $145.20
- Revenue Next Year
- KNOP $1.75
- GNFT N/A
- P/E Ratio
- KNOP N/A
- GNFT $7.51
- Revenue Growth
- KNOP 4.75
- GNFT 175.45
- 52 Week Low
- KNOP $4.94
- GNFT $3.35
- 52 Week High
- KNOP $9.11
- GNFT $6.42
- Technical
- Relative Strength Index (RSI)
- KNOP 45.64
- GNFT 43.20
- Support Level
- KNOP $5.87
- GNFT $3.47
- Resistance Level
- KNOP $6.14
- GNFT $3.70
- Average True Range (ATR)
- KNOP 0.23
- GNFT 0.10
- MACD
- KNOP -0.02
- GNFT 0.04
- Stochastic Oscillator
- KNOP 12.14
- GNFT 45.45
About KNOP KNOT Offshore Partners LP Common Units representing Limited Partner Interests
KNOT Offshore Partners LP owns, operates, and shuttles tankers under long-term charters in the North Sea and Brazil. The company provides crude oil loading, transportation, and storage services under time charters and bareboat charters. The Partnership is formed for acquiring ownership interests in over four shuttle tankers owned by Knutsen NYK Offshore Tankers AS (KNOT). It operates through the shuttle tanker market segment.
About GNFT GENFIT S.A.
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.